Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of biologically active compounds where stereochemistry plays a critical role. Its protected pyrrolidine structure makes it valuable in peptide mimetics and protease inhibitor design. Commonly employed in medicinal chemistry for constructing enantiomerically pure drug candidates, especially in CNS agents and metabolic disorder treatments. The methylcarbamoyl group allows further functionalization, enabling diverse derivatization for structure-activity relationship studies.